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oped and developing countries spend most financial
health care resources on CVD—more than all cancers
combined.1 In both the United States and Europe, the
estimated annual costs for CVD are 282 and 169 billion
euros, respectively, with direct health care costs account-
ing for approximately 60% of the costs (eg, hospital
services, physicians, and prescribed medication). The
surplus represents indirect costs from lost productivity
and informal care.2,3 With atherosclerosis as the under-
lying cause for the majority of clinical CVD events,3 early
detection of subclinical atherosclerotic plaque burden
(SAPB) and consequent action may carry significant
reductions in all costs. Atherosclerosis takes decades to
develop symptoms, offering opportunities for early
detection and customized lifestyle modifications to
prevent CVD manifestations. Recently, the clinical
significance of subclinical detection was emphasized in
the High-Risk Plaque-US BioImage Study. This prospective
study among approximately 6000 asymptomatic adults
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tion with imaging techniques (coronary artery calcium
score [CACS] and carotid 3D ultrasonography) to classical
risk factors for CVD risk prediction.4
A healthy lifestyle that includes being physically active,
not sitting toomuch, eating a healthy diet, and not smoking
will contribute to improved cardiovascular health.5-11
WHO has identified the workplace as a key setting for
promoting a healthy lifestyle for the prevention and
control of noncommunicable diseases.12 A number of
reviews have indicated that worksite health promotion
programs can be effective in promoting healthy lifestyle,
including improving physical activity, sedentary and
dietary behaviors, as well as smoking cessation.13-19
Positive effects of such lifestyle interventions on
work-related outcomes have also been reported and
include improvements in sickness absenteeism, presen-
teeism, and work ability.14,20-22
The Progression and Early detection of Subclinical
Atherosclerosis (PESA) cohort started in 2010 and consists
of 4,184 asymptomatic adult bank employees of the Banco
de Santander Headquarters in Madrid, Spain (PESA:
NCT01410318). PESA evaluates the presence and progres-
sion of subclinical atherosclerotic lesions in the carotid,
aortic, coronary, and iliofemoral territories using noninva-
sive advanced imaging techniques.23 The value of SAPB
identification and stratification driven by imaging data in a
30-monthworksite-based lifestyle programwill be assessed
in the current TANSNIP-PESA study (Trans-Atlantic Net-
work to study Stepwise Non-invasive Imaging as a tool for
CVD Prognosis and prevention) nested within the cohort
study. The network consists of experts in the fields of CVD
imaging, diagnostics, worksite health promotion, and
clinical trials who are carrying out several studies in the
subclinical atherosclerosis field with the unifying purpose
of enhancing SAPB stratification and enabling
novel targeted therapies and SAPB reduction strategies.
The current TANSNIP-PESA study is linked to the cohort
study.Study objectives
The primary objective of the TANSNIP-PESA study is to
determine the effectiveness and cost-effectiveness of a
comprehensive 30-month worksite-based lifestyle pro-
gram in a population of asymptomatic bank employees
from the PESA cohort who have either a high or a low
degree of imaging-defined SAPB. The primary outcome
measure is the adapted Fuster-BEWAT CVD risk and
lifestyle composite score, and secondary outcome
measures include physical activity, sedentary time,
standing time, diet, smoking, anthropometric measures,
blood biomarkers, self-rated health, work-related out-
comes, health care consumption, program process
measures, and cost measures.The secondary objective is to determine whether the
level of compliance with and effectiveness of the lifestyle
program is different in those having a high degree of
SAPB compared with those with a low degree of SAPB.
Because of the higher urgency in the high-SAPB group,




A randomized controlled trial (RCT) stratified by SAPB
will be conducted, nested within the PESA cohort.23 Our
target population will be 4,184 middle-aged (40-60 years)
bank employees of the Banco de SantanderHeadquarters in
Madrid (Spain) who are currently part of the PESA cohort.
One arm (n = 260) will focus on a sample of bank
employees drawn from the PESA cohort with a high
degree of imaging-defined SAPB, and the second arm (n =
590) will be conducted on a sample of the PESA cohort
drawn from the group with a low degree of
imaging-defined SAPB (Figure 1). In both stratified SAPB
arms, the participants will be randomized into a lifestyle
program or into standard care for a 3-year period after
completing the baseline assessments that will consist of
completing several questionnaires, wearing for 7 consec-
utive days the activPAL activity monitor, and drawing a
fasting blood sample. Primary follow-up assessments will
be done at year 1, year 2, and year 3 for both standard-care
and intervention group. Each participant in the
standard-care group will receive care as usual, provided
by their own occupational physician and other possible
care providers. Participants in the intervention group will
receive the intervention on top of standard care.
Primary follow-up assessments will be done at year 1,
year 2, and year 3. The study protocol has been approved
by the Ethics Committee of Instituto de Salud Carlos III in
Madrid. All participants will provide written informed
consent. The study will follow the Consolidated Standards
of Reporting Trials guidelines.24
Participants
Participants who comply with the criteria stated in
Table I will be eligible for participation in the RCT. High
or low degree of imaging-defined SAPB will be deter-
mined based on noninvasive vascular imaging data from
the PESA cohort study. Subclinical atherosclerosis is
defined as the presence of atherosclerotic plaques by
using 2D ultrasonography of the carotids, abdominal
aorta, and iliofemoral arteries or by assessment of CACS
by computed tomography (CT).25
Randomization and blinding
A stratified computerized fixed block randomization
will take place at the individual level after collection of all
baseline information. Participants will be stratified
Figure 1
To be assessed for eligibility
(n = 4184)
To be excluded: 
-Not meeting inclusion 
criteria
-Meeting exclusion criteria
-Declined to participate 
Allocated to 
intervention 
Low SAPB*  
n = 295







Target n = 590
SAPB= Subclinical Atherosclerotic Plaque Burden. 
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Follow-Up year 1 
Follow-Up year 2 
Follow-Up year 3 
Follow-Up 4, 6 and 9 months MI sessions 17, biweekly -
up to 3 months 
MI session 8: 5 months
MI session 9: 10 months
High SAPB
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MI sessions 1-7, biweekly 
up to 3 months 
MI session 8: 5 months
MI session 9: 10 months
MI session 10: 16 months
MI session 11: 22 months Follow-Up 15, 18 and 21months
MI session 10: 16 months
MI session 11: 22 months
Follow-Up 27, 30 and 33 months 
MI session 12: 30 months MI session 12: 30 months
Study flowchart.
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SAPB. Group allocation will be concealed for research
staff involved in data collection and cleaning.
Recruitment
The study will take place at Banco de Santander
Headquarters in Madrid (Spain). Eligible participants
will be recruited from May 2015 until the end of 2016.
Information sessions will be organized for all participants
of the PESA cohort study to introduce the RCT and topresent the main aims and procedures of the study.
Recruitment emails will be sent to all 4,184 PESA
cohort participants with a link to express online
interest in participation. Interested individuals will be
invited to a visit with the research nurse to further
explain the study, to answer remaining questions, to
obtain written informed consent for participation in
the study, and to complete the baseline assessment. At
the time of submission of this article, 712 participants
were included.
Table I. Inclusion and exclusion criteria
Inclusion
criteria
• Employees aged 40 to 60 y from the PESA cohort study;
• Employees that will complete all 3 baseline assessment elements (ie, wearing an activPAL, drawing blood, and
completing the questionnaire);
• Employees that can be stratified into a high or low degree of imaging-defined SAPB. High degree of
imaging-defined SAPB will be defined as a high burden of atherosclerotic disease detected either by 2D
ultrasonography (upper tertile sum of maximum thickness of the plaques or CACS Agatston score by CT ≥ 1
point).23 Low degree of imaging-defined SAPB will be defined as having a CACS Agatston score of zero and
no plaque by 2D ultrasonography or being in the lowest 2 tertiles of plaque burden.25 Participants without
plaque burden but with a BMI ≥ 25 or reporting at least 1 unhealthy lifestyle behavior in their last PESA visit
(ie, b150 min/wk of at least moderate-intensity physical activity assessed by accelerometer, sitting N7 h/d as
assessed by accelerometer, not meeting Mediterranean diet guidelines as assessed by a computerized dietary
history tool previously developed and validated in the EPIC-Spain study26 and adapted by ENRICA
investigators,27 or smoking) will also be included in the low SAPB group.
Exclusion
criteria
• Employees that have prior CVD history (myocardial infarction, angina pectoris, stroke, peripheral vascular
disease, aortic aneurysm, angioplasty, heart surgery, atrial fibrillation, or any other heart disease);
• Active treatment for cancer, history of transplant with active immunosuppressive or immunomodulator
treatment;
• Morbid obesity (body mass index ≥40 kg/m2);
• Any disease that decreases life expectancy to ≤3 y;
• Employees will also be excluded if they are pregnant or lactating;
• Or any condition that could affect adherence to the study procedures;
• Employees without plaque burden, with a healthy BMI, andwith a healthy lifestyle will be excluded from the RCT.
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The lifestyle program takes a socioecological approach.28
The socioecological model of health promotion combines
different approaches, focusing on making changes to the
individual as well as to the social, physical, and/or
organizational environment. This is in line with the WHO
“healthy workplace model,” which has emphasized that
best practice interventions should involve individual,
environmental, and organizational change components.29
The program has been developed in a systematic way
using basics derived from the intervention mapping
protocol,30 such as a needs assessment, definition of
program objectives, individual and environmental strate-
gy selection, defining content program, and piloting. A
blueprint for the program was developed in cooperation
with employees from Banco de Santander in Madrid.
End-user tailoring and involvement included (1) mapping
lifestyle-related cardiovascular risk factors of the PESA
cohort study participants, (2) mapping existing lifestyle
policies of Banco de Santander and key determinants of
lifestyle behaviors through focus group interviews with
end-users, and (3) performing an environmental audit at
Banco de Santander by investigating the presence of
facilities for promoting a healthy lifestyle. After this, the
following 3 program objectives were formulated: (1)
increasing daily physical activity by reaching at least
10,000 steps per day, (2) reducing sedentary time by
alternating sitting and standing throughout the day, and
(3) promoting healthy eating with a strong focus on
adopting a Mediterranean diet.The program integrates 3 key components: (a) 12
motivational interviewing (MI) sessions that will be
conducted by a trained psychologist over a 30-month
period, (b) a wrist-worn physical activity tracker with
smartphone connectivity, and (c) a sit-stand workstation
to provide more opportunity to alternate between sitting
and standing during work.
Participants randomized to the standard care group will
not receive the lifestyle program but care as usual, at the
discretion of their occupational physician (which could
involve informing the employee about his CVD risk
profile) and other possible care providers. Participants in
the intervention group will receive the program on top of
standard care.
A. Personalized lifestyle counseling
Trained psychologists will provide the participants 12
MI sessions over a period of 30 months. Well-established
behavioral change strategies will be integrated in the MI
sessions, including self-monitoring, goal setting, planning,
reinforcement, relapse prevention, and overcoming
barriers. The psychologist will tailor the intervention to
the participant's specific needs and preferences. The MI
sessions will also be aimed at raising awareness of the
employees' PESA-assessed SAPB/cardiovascular health
profile. The first 7 MI counseling sessions will take
place biweekly over the first 3 months (0, 2, 4, 6, 8, 10,
and 12 weeks) and will last for approximately 1 hour. The
eighth counseling session will be at 5 months followed by
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sessions), all lasting 30 minutes. Details on the content
of the MI sessions can be found in the supplemental
appendix.
The use of the physical activity tracker and sit-stand
workstation is an integral part of all MI sessions and will
be included in personal goals and action plans. Attention
will be paid during all sessions to the social environment
by incorporating possible social support from family,
friends, and colleagues. The MI sessions will also use a
workbook for the participant to refer back to, which
summarizes the intervention content session by session.
The workbook will also be used to record specific short-
and longer-term behavioral change goals and action
plans, which the participant will formulate with the
assistance of the coach. The workbook will also provide
helpful examples of behavior change, healthy lifestyles,
and useful tools. Furthermore, participants can visit the
specific Facebook page of the intervention group for
extra information on lifestyle behaviors through appeal-
ing graphics, illustrations, and videos posted by the
research team, as well as to share experiences with other
intervention participants.
Personal progress will be registered in the intervention
database for the psychologist to review and prepare
future sessions. The psychologists will receive an initial
2-day training in MI by a Spanish MI expert and will have 3
coaching feedback sessions with the same MI expert over
Skype. Adherence to MI techniques will be assessed by
Motivational Interviewing Treatment Integrity (MITI)31
scoring every 6 months. These scores will be used in the
feedback session to improve further the skills of the
psychologists. The MITI score that will be obtained on
the second day of the initial MI training will serve as
reference for future MITI scores.B. Physical activity tracker
Participants in the current program will receive the
Fitbit Flex at MI session 2. This is a next-generation
activity tracker with wireless smartphone, tablet, and
computer connectivity. The Fitbit allows participants to
use common effective behavioral change techniques,
such as self-monitoring, goal setting, real-time feedback,
and simple rewards systems. A personalized dashboard
on the Fitbit Web site provides summaries of the
participant's physical activity, stimulating prompts and
rewards, and allows for social media sharing. Within the
Fitbit Web site, a separate group has been created for the
intervention group. This allows participants to anony-
mously benchmark their personal scores against the
average daily step score of the whole intervention
group. The Fitbit use will be an integral part of the MI
sessions.C. Sit-stand workstation
Participants will receive an Ergotron sit-stand worksta-
tion (model Workfit P or T) in the first few weeks of the
program (MI session 3). This can be integrated into a
normal working desk. The sit-stand workstation use will
be an integral part of the MI sessions.
Outcome assessments
Timing of assessments
Each participant will have 4 study visits: baseline and 1-,
2-, and 3-year follow-up (Figure 1). Each study visit
includes anthropometric assessments, blood collection
for cardiometabolic biomarkers, wearing an activPAL
activity monitor for 7 consecutive days, and online
completed questionnaires. Additional online question-
naires will be completed at 4 and 6 months after baseline
to map intermediary behavior change. Furthermore, data
for the economic evaluation on sickness absenteeism,
presenteeism, and health care utilization will be collected
each 3 months up to 36 months. Quantitative data for the
process evaluation will be collected at 4, 12, 24, and 33
months. Information about translation of the question-
naires is given in the appendix. Qualitative data collection
for process evaluation purposes will be completed with
varying groups after the first 7 MI sessions, after MI
session 9, and after MI session 12. All assessments and
outcomes are summarized in Table II.
After providing written inform consent at the research
center, a research nurse will perform the physical
baseline assessments and provide participants with an
activPAL activity monitor. After wearing the activPAL for
7 full days, it is returned by mail to the research center.
The participant will receive the link to the online baseline
questionnaire (to a secured database) by e-mail after the
inclusion visit. At all follow-up measurements, the same
order of assessments will be applied.
Primary outcome adapted Fuster-BEWAT score
The primary outcome measure is an adapted version of
the Fuster-BEWAT score.32 This is a CVD risk and lifestyle
composite score, which consists of systolic and diastolic
blood pressure (BP), physical activity, sedentary time,
body mass index, fruit and vegetable consumption (as a
proxy for overall diet), and smoking (Table III). The
adapted Fuster-BEWAT will be assessed at baseline and at
1-, 2-, and 3-year follow-up. The initial Fuster-BEWAT
score will also be calculated in addition as a secondary
outcome for future testing of psychometric properties of
the adapted Fuster-BEWAT score.
Secondary outcomes
Secondary outcomes are individual changes in mean
scores of lifestyle behaviors (including physical activity,
sedentary time, standing, diet, and smoking) as well as
Table II. Overview of outcomes used in the study
Outcome Baseline
Follow-up assessments (m)
4 6 9 12 15 18 21 24 27 30 33 36
Adapted Fuster-BEWAT X X X X
Original Fuster-BEWAT X X X X
Objective physical activity/sedentary time
activPAL activity monitor X X X X
Self-reported lifestyle behaviors
Physical activity (IPAQ short) X X X X X X
Occupational activity (OSPAQ) X X X X X X
Sedentary behavior (WSQ) X X X X X X
Standing X X X X
Diet (MEDAS) X X X X X
Smoking status X X X X
Sleeping (Sleep Habits Questionnaire) X X X X
Physical assessments
Waist circumference X X X X
Body height X
Body weight X X X X
Blood pressure X X X X
Cardiometabolic biomarkers
Complete blood count and chemistry panel X X X X
Specific biomarkers related to subclinical atherosclerosis X X
Psychosocial assessments
Depression (CES-D) X X X X
Perceived stress (PSS-14) X X X X
Social support (ESSI) X X X X
Job strain (JCQ) X X X X
Quality of life (EQ-5D-5L) X X X X
Relaxation and detachment (RECQ) X X X X
Self-rated Health (EQ VAS) X X X X




Marital status X X X X
Working h/wk X X X X
Employment status X X X X
Job type X X X X
Income X X X X
Education level X X X X
Economic evaluation
Sickness absenteeism (WHO-HPQ) X X X X X X X X X X X X
Presenteeism (WHO-HPQ) X X X X X X X X X X X X
Health care consumption X X X X X X X X X X X X
Process evaluation
Participant questionnaire X X X X
Participant focus group interview X X X
Psychologist checklist X X X X X
Psychologist individual interview X X X X X
MITI scoring X X X X X
Stakeholder checklist X X X
Stakeholder interview X X X
Linkage to PESA
Noninvasive imaging 2D/3D ultrasonography and CACS-CT X
IPAQ, International Physical Activity Questionnaire; OSPAQ, Occupational Sitting and Physical Activity Questionnaire; WSQ, Workforce Sitting Questionnaire; MEDAS,
Mediterranean Diet Adherence Screener; CES-D, Center for Epidemiologic Studies Depression Scale; PSS, Perceived Stress Scale; ESSI, ENRICHD Social Support Instrument; JCQ, job
content questionnaire; EQ-5D-5L, EuroQol five dimensions questionnaire; RECQ, recovery experience questionnaire; EQ VAS, EuroQol Visual Analogue Scale; VITA-16, Vitality
16-item questionnaire; WHO-HPQ, WHO Health and Work Performance Questionnaire; MITI, Motivational Integrity score; PESA, Progression of Early Subclinical Atherosclerosis'
cohort; CACS-CT, Cardiac CT for Calcium Scoring.
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Table III. Scoring of different elements of the adapted Fuster-BEWAT primary outcome measure.
Score 0 1 2 3 4
Systolic/diastolic blood pressure⁎ (mm Hg) ≥140/90 134-139/87-89 128-133/84-86 121-127/81-83 ≤120/80
Physical activity (steps/d) b5500 5500-6999 7000-8499 8500-9999 ≥10,000
Sitting (h/d) ≥12.5 11- b 12.5 9.5- b 11 8- b 9.5 b8
BMI (kg/m2)† ≥32 30-31.9 27-29.9 25-26.9 b25
Fruit & vegetable consumption (servings/d) ≤1 2 3 4 ≥5
Smoking (units/d) N20 10-20 1-9 b1 0
Total score ranges from 0 to 24, with a higher score indicating a lower risk score.
⁎ If systolic and diastolic blood pressures do not fall in the same group, then the participant is assigned to the group with the relatively highest blood pressure (ie, systolic or diastolic).
†At follow-up visits, a N5% decrease in BMI will add 1 extra point in the BMI score except for those participants who have changed BMI categories since baseline or are already in
the normal-weight category (BMI b25). Similarly, a N5% increase in BMI at follow-up will mean 1 point less in the BMI score except for participants who have changed BMI
categories since baseline or with BMI ≥32.
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self-rated health, work-related outcomes, health care
consumption, program process measures, and cost
measures at different measurement points.
Lifestyle behaviors assessments
Physical activity and sedentary time will be objectively
assessed with an activPAL activity monitor (PAL Tech-
nologies Limited, Glasgow, UK) attached to the front of
the participant's thigh for at least 7 consecutive full days.
Research has shown that this activPAL activity monitor is
valid and responsive.33,34 Participants will also daily
complete a short diary reporting the exact wearing times
(ie, the time at which the activPAL was put on and off)
and the times of starting and finishing work (ie, to
determine the exact wearing time at work). The physical
activity and sedentary behavior data from the activPAL
will also be used for the primary outcome, the adapted
Fuster-BEWAT score. The following questionnaires re-
garding physical activity and sedentary behavior will be
administered: the International Physical Activity Ques-
tionnaire short form (7 items)35; the Occupational Sitting
and Physical Activity Questionnaire to assess time spent
sitting, standing, and activity at work36; the Workforce
Sitting Questionnaire measuring total and domain-specific
sitting time based on working and nonworking days37;
and single questions to assess average daily standing.
Data on dietary habits will be collected with the
Mediterranean Diet Adherence Screener (MEDAS).38
MEDAS is a short 14-item questionnaire aimed to assess
adherence to a Mediterranean Diet. MEDAS has 2 items
asking about fruit and vegetable consumption. Smoking
status will be a self-reported measure, as well as the
average number of cigarettes or other tobacco products
consumed daily. Furthermore, sleeping will be measured
using the Sleep Habits Questionnaire consisting of 21
items developed by the Sleep Heart Health Study.39
Physical assessments
Waist circumference, body height, body weight, and BP
will be measured at the research center and will all beregistered in the database. Waist circumference will be
measured twice with a tape measure to the nearest 0.1
cm at the midpoint between the lower border of the ribs
and the iliac crest. Body height will be measured on bare
feet using a stadiometer (Asimed Height Rod HM-200M)
to the nearest 0.1 cm. Body weight will be measured
using the Asimed HM-200M scale on bare feet
and wearing only light garments. Body mass index
(BMI; kg/m2) will be calculated from the body height
and weight obtained from the above measurements. BP
(in mm Hg) will be assessed 3 times with a fully
automated BP monitor (OMRON HBP 1300), and all
measurement points are to be registered in the database.
The cuff will be placed on the right upper arm while the
arm is rested on a table.
Cardiometabolic biomarkers
Complete blood count and chemistry panel will be
obtained at baseline and at every follow-up visit. Specific
biomarkers related to subclinical atherosclerosis will be
analyzed at baseline and at follow-up year 1. A preliminary
list of the planned biomarkers to measure is provided in
the Appendix. Approximately 40 mL will be drawn
during the baseline visit. Baseline blood samples will also
be stored at −80°C for future omics (proteomics and
metabolomics) analysis. Each aliquot will have a unique
identifier by using a laboratory information management
system to guarantee an accurate tracking of all proce-
dures. The sample will be analyzed by an accredited
laboratory.
Psychosocial assessment
Participants will complete validated psychosocial
questionnaires. Depression will be measured using the
20-item Center for Epidemiologic Studies Depression
Scale.40 Perceived stress will be measured using the
14-item Perceived Stress Scale.41 Social support will be
measured using the official Spanish-translated ENRICHD
Social Support Instrument, which is a 7-item self-report
survey to test emotional, informational, instrumental, and
appraisal support.42 Job strain will be measured with an
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Job Content Questionnaire (JCQ) from the job content
center using 17 items of the original 35 JCQ items.43 The
JCQ assesses skill discretion (eg, learning new things,
developing own abilities), decision authority (eg, allows
own decisions), psychological job demands (eg, work
fast, conflicting demands), and job insecurity (eg, steady
work). Quality of life will be self-reported using the
EuroQol (EQ-5D-5L),44 which consists of 5 dimensions
(ie, mobility, self-care, usual activities, pain/discomfort,
anxiety/depression) and 5 report levels (ie, no problems,
slight problems, moderate problems, severe problems,
and extreme problems). Self-rated health will be assessed
with the EuroQol Visual Analogue Scale. Relaxation and
detachment after work will be measured using 8 items
from the Recovery Experience Questionnaire.45 Vitality
will be measured using the Vitality 16-item questionnaire,
which assesses energy, motivation, and resilience.46
Personal characteristics
Sociodemographic information, including age, gender,
marital status, working hours per week, job status, job
type, income and education level, will be assessed.
Economic evaluation
To evaluate the cost-effectiveness of the lifestyle
program, sickness absenteeism, presenteeism (ie, working
while feeling ill), and health care consumption (eg, general
practitioner, allied health professionals, complementary
medicine consumption) will be assessed every 3 months
until 36 months after baseline. Sickness absenteeism and
presenteeism will be assessed with items from the WHO
Health and Work Performance Questionnaire
(WHO-HPQ).47 Presenteeism is conceptualized in the
WHO-HPQ as a measure of actual work performance in
relation to best performance, irrespective of the presence
or absence of health complaints. Sickness absenteeismwill
be self-reported using the WHO-HPQ in hours per month.
Process evaluation
The RCT also include a process evaluation, which is
based on the framework of evaluating complex interven-
tions.48 The feasibility of the program will be investigated
using quantitative and qualitative methods on 3 levels: the
participant, the psychologist, and the stakeholder.
Further details are given in the Appendix.Linkage to data collected in PESA
The RCT is linked to the PESA cohort study. In PESA, a
wealth of data is collected, including behavioral lifestyle,
anthropometric, blood biomarker, and imaging out-
comes, which have been described in detail elsewhere.
23 Within the PESA cohort, participants are assessed at the
PESA baseline and 3 and 6 years after baseline.
Participants of the current RCT have all completed theirPESA baseline assessment and at time of inclusion in the
RCT are due in 1 year's time for either their 3-year or their
6-year PESA assessment. The noninvasive imaging tech-
niques that are performed in PESA include: 2D ultraso-
nography (2D-US) of carotids, abdominal aorta and
iliofemoral arteries, 3D ultrasonography (3D-US) of
carotid and femoral arteries, and CACS by CT scanning.
Participants with a high degree of SAPB will additionally
receive advanced imaging consisting of fludeoxyglucose
positron emission tomography–magnetic resonance im-
aging of carotid and iliofemoral territories.
Sample size
Based on baseline information (n = 4,149) from the
PESA cohort study on the adapted Fuster-BEWAT score
(low degree of SAPB mean score [SD] = 14.53 [3.49];
high degree of SAPB mean score [SD] = 13.28 [3.79]), 2
separate statistical power calculations were performed.
For both power calculations a power of 80% and an α of
5% is used, with an anticipated dropout of no more than
20% over 3 years. The 2 power calculations revealed that
the following sample sizes would be able to detect
clinically relevant changes in the primary outcome:
I. If the low degree of SAPB arm would recruit 590
participants: a change of 0.89 in the adapted
Fuster-BEWAT score would be detectable. On the
PESA baseline score, this would translate in a
detectable relative change of 6.13%.
II. If the high degree of SAPB arm would recruit 260
participants: a change of 1.45 in the adapted
Fuster-BEWAT score would be detectable. On the
PESA baseline score, this would translate in a
detectable relative change of 10.92%.
Given our previous experience with lifestyle intervention
studies using outcomes such as the BEWAT score, we are
well powered to detect change that would be clinically
relevant and thus meaningful for the respective cohorts.32
Furthermore, a larger effect is anticipated in the high degree
of SAPB arm, as there ismore room for improvement. Finally,
the sample sizes for both arms are limited by the boundaries
of the sampling pool size of the PESA cohort.
Statistical analyses
Effectiveness analyses
Linear mixed effect models with outcome as the
dependent variable will be performed on an
intention-to-treat basis; the group (intervention vs stan-
dard care) will be modeled as independent variable and
time of follow-up measurements (T1, T2, and T3) as fixed
factor, while we will adjust for the baseline value of the
primary outcome. Per-protocol analyses will be per-
formed to investigate the effects of the intervention in
participants with high compliance to the lifestyle
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P b .05 will be considered statistically significant. All
analyses will be performed with SPSS 20.0 (SPSS Inc,
Chicago, IL).
Cost-effectiveness analyses
The cost-effectiveness analyses will take a societal and
employer's perspective. Analyses will be performed
according to the intention-to-treat principle. In the main
analysis, missing economic data will be imputed using
multiple imputation techniques.49 Sensitivity analyses will
be done to assess the robustness of the results. Total
societal and employer's costs will be estimated and
compared between the intervention and control group.
The 95% confidence intervals will be estimated using
approximate bootstrap confidence intervals.50 Societal
costs will include all cost measures described above in
the outcome section. For the employer's perspective, only
costs relevant to the employer will be included (ie,
intervention and productivity-related costs: consisting of
sickness absenteeism and presenteeism). For the
cost-effectiveness analysis, incremental cost-effectiveness
ratios will be calculated by dividing the difference in costs
between groups to their difference in effects on the
primary outcome measure (societal perspective), and
outcome measures relevant to the company (employer's
perspective). Bootstrapped cost-effect pairs will be graph-
ically presented on cost-effectiveness planes. 51
Cost-effectiveness acceptability curves will be generated
showing the probability for cost-effectiveness of the
intervention at different ceiling ratios.Discussion
This article describes the study protocol of an RCT
whose primary objective will be to determine the
effectiveness of a 30-month worksite-based program
that aims to promote cardiovascular health through
improving lifestyle behaviors in participating
middle-aged bank employees with a high or low degree
of SAPB. The RCT will also determine whether partici-
pant's awareness of their degree of SAPB will influence
their compliance with the lifestyle program as well as its
effectiveness.
The trial will include a comprehensive evaluation with
state-of-the-art assessment tools including objective as-
sessments of physical activity and sedentary behavior,
anthropometrics and blood biomarkers, psychosocial and
work-related outcomes, as well as an economic and a
process evaluation. The current program is theory driven
and systematically designed to improve cardiovascular
health. The participants will receive 12 MI sessions. MI is
a collaborative, goal-oriented counseling style that can be
translated into 4 generic principles, namely, expressing
empathy by reflective listening, identifying discrepancies
between participant's goals and current behavior, rollingwith resistance by adjusting to participant's resistance
rather than opposing it, and supporting self-efficacy.52
Previous systematic reviews and meta-analyses have
revealed that MI is effective in facilitating behavioral
change across a range of lifestyle domains.53-55 Further-
more, the participants will receive a physical activity
tracker. The Lancet special issue on physical activity
showed that pedometers were the most effective
intervention tool to improve physical activity.56 The last
intervention program component involves a sit-stand
workstation. Recent literature reviews have shown that
lifestyle programs can reduce sedentary time.16 For the
workplace setting, especially sit-stand workstations have
been shown to be effective in reducing occupational
sitting time, albeit longer-term studies are needed to
determine maintenance and long-term impact on behav-
ioral, work, and health outcomes.17 Sit-stand worksta-
tions allow employees to adjust the height of their
workstation, including the computer screen, keyboard,
and mouse, and allows them to easily switch between
sitting and standing throughout the working day.
Reductions in sedentary time are most successfully
achieved by incorporating environmental modifications
(such as a sit-stand workstation) and self-regulatory skills
training (such as MI).57 The current study will be one of
the first to evaluate longer-term effectiveness of sit-stand
workstations, as well as their impact on health and
work-related outcomes.
Another strength is that the study is closely linked to
the existing PESA cohort study, which has the advantage
that more and better data will be available on the lifestyle
behaviors and health of the participants in the RCT. This
will allow for studying natural temporal changes in
lifestyle behaviors and SAPB pre-, during, and post- RCT
over a 6- to 8-year period within the control group and,
more importantly, how the lifestyle program impacted on
these changes in the intervention group. The link to the
PESA cohort also makes state-of-the-art SAPB imaging data
available for the RCT participants as well as longitudinal
blood biomarker data.
The focus of the lifestyle program to achieve long-term
behavior change and the integration of MI maintenance
sessions starting at 5 months up to 30 months after
baseline are also a strength of the TANSNIP-PESA study.
Most lifestyle programs are often focused on short-term
behavioral change, and few studies have a follow-up
assessment beyond 1 year postbaseline. As only
longer-term behavioral lifestyle changes can have a lasting
impact on cardiovascular health, the current study also
includes assessments at 2- and 3-year follow-up.
If shown to be (cost-)effective, the lifestyle program has
the potential to be implemented and evaluated in other
work settings. The role of SAPB imaging in identifying
at-risk populations and its possible role in motivating
people through SAPB communication integrated in
lifestyle programs could be crucial in achieving better
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grams. Nevertheless, implementation of structural SAPB
screening might also be challenging because of cost
implications. However, advances in technology make
noninvasive testing of SAPB more widely available, and
this is likely to provide new windows for opportunities at
community and worksite level to prevent or detect
atherosclerosis at an early stage. This is in line with other
screening examples such as the early detection and
prevention of breast cancer and colon cancer. Imple-
mentation of screening for SAPB needs to be founded on
strong evidence and requires extensive study on health
benefits and cost efficiency.
A limitation of the study is that the sample is not truly
population based but rather a convenience sample.
Although this may limit generalizability to the general
population, our study results will be broadly applicable to
worksite wellness programs involving middle-aged pro-
fessionals. Like other lifestyle program RCTs, our study
may suffer from selection bias related to the level of
motivation with regard to willingness to adopt a healthier
lifestyle. To address this limitation, we will compare data
for those who participate in the RCT and those who do
not using the rich data available for the target population
(ie, participants in PESA). The link between the current
RCT and PESA not only is a strength but also comes with
some challenges. Especially, the coordination between
the RCT, PESA, and the bank's occupational health
service will require coordination efforts. Furthermore,
participation in both the RCT and PESA might also
influence the results of both studies, as the assessments
and participation in the SAPB imaging might influence
participant's lifestyle behaviors. It is, for example,
possible that those in the control group who are aware
of their high SAPB will attempt to improve their lifestyle,
which would make the SAPB screening an intervention in
itself. Nevertheless, long-term behavior lifestyle change is
challenging, and if the extensive lifestyle program offered
to the intervention group cannot do better than a possibly
self-motivated control group, it is probably not worth
pursuing further, and the SAPB screening in itself might
be sufficient.
In conclusion, the TANSNIP-PESA study will provide
insights into the effectiveness of a worksite-based lifestyle
program to promote cardiovascular health compared
with standard care in participants with a high or low
degree of imaging-defined SAPB.Financial support
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